Deep Lens
Deep Lens (operating as Paradigm Health) is a Columbus, Ohio-based healthcare technology company that operates an intelligent clinical trial recruitment and research platform connecting patients, providers, and trial sponsors to accelerate oncology trial enrollment.
- Company typePrivate
- Founded2017
- HeadquartersColumbus, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Deep Lens does
Deep Lens, operating commercially as Paradigm Health, is a U.S.-based healthcare technology company founded in 2017 and headquartered in Columbus, Ohio. The company builds an intelligent research platform that connects patients, healthcare providers, and clinical trial sponsors with the goal of accelerating patient recruitment into oncology and other clinical trials, addressing the industry-wide problem that roughly 80% of drugs fail to meet enrollment targets. The platform combines technology and services, integrating directly with healthcare provider organizations so that clinical research capabilities are embedded into routine patient care workflows rather than operated as a separate sponsor-centric function.
The platform is organized as a multi-product suite spanning protocol optimization, feasibility and site selection, patient identification and enrollment acceleration, trial data capture and delivery, and a post-approval/late-stage clinical evidence platform oriented toward community care providers. Differentiation is described in terms of integration and interoperability with provider organizations, accuracy and precision in patient matching, and the ability to support a single site across multiple sponsors and trial phases. The core customer-facing outcomes demonstrated to date include a 45% increase in clinical trial patient enrollment over two years at reference customer Highlands Oncology, alongside reduced research-department burden.
The business model is subscription-based, with revenue generated from both trial sponsors (protocol optimization, feasibility, enrollment, data collection services) and healthcare provider research sites (integration services and research department enablement). Go-to-market is a direct enterprise sales motion with consultative, solution-selling engagement across both constituencies, supplemented by content marketing, LinkedIn presence, email newsletters, and participation in industry events. The company has disclosed approximately $17.2 million across two funding rounds — a $3.2M seed in September 2018 and a $14.0M Series A in April 2019 led by Northpond Ventures and Sierra Ventures — and operates with 11-50 employees.
Deep Lens firmographics
Firmographics- Name
- Deep Lens
- Website
- https://deeplens.ai
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 11–50 employees
- Short description
- Deep Lens (operating as Paradigm Health) is a Columbus, Ohio-based healthcare technology company that operates an intelligent clinical trial recruitment and research platform connecting patients, providers, and trial sponsors to accelerate oncology trial enrollment.
- Ownership category
- akta.pro rank
Deep Lens industry classification
Industry- Product category
- Clinical Trial Technology
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
- akta.pro secondary industry
- Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE)
Keywords
Where Deep Lens is headquartered
LocationHeadquarters
- HQ city
- Columbus
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Deep Lens business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Platform Services for Sponsors: Technology and services platform connecting sponsors with research sites for clinical trial management, patient recruitment, and data collection
- Provider Integration Services: Integration services with healthcare provider organizations enabling clinical research capabilities
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Deep Lens product offering
Product offeringCore offering
Deep Lens (now operating as Paradigm Health) provides an AI-powered clinical trial recruitment and patient identification platform. The company matches patients to oncology and other clinical trials by integrating with electronic health record (EHR) data at research sites, enabling sponsors and sites to accelerate enrollment, optimize protocol design, and improve feasibility assessment.
Differentiator
Problem solved
Functional benefit
Products and services
- Protocol Optimization
- Feasibility & Site Selection
- Patient Identification & Enrollment Acceleration
- Trial Data Collection & Delivery
- Post-Approval and Late-Stage Clinical Evidence
- Solutions For Research Sites
Quantifiable outcome
- 45% increase in clinical trial patient enrollment over two years
- +1 more outcomes
Companies that use Deep Lens
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Deep Lens technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Deep Lens partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Highlands OncologycoreCustomer case study partner demonstrating 45% increase in patient enrollment and reduced research burden. Highlands Oncology serves as a reference customer and proof point for Paradigm Health's platform effectiveness in oncology research settings.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Deep Lens competitors and assessment
Company assessmentDirect peers
- Deep 6 AI: AI-driven patient identification and clinical trial matching platform that integrates with EHR systems to accelerate oncology and specialty trial recruitment; the closest direct peer to Deep Lens/Paradigm Health in mission, customer base, and technology approach.
- Mendel: AI platform that structures EMR data and matches patients to clinical trials and real-world evidence cohorts; competes directly with Deep Lens in serving sponsors and provider research sites for protocol-level patient feasibility.
- BEKhealth: AI-based clinical trial patient identification and cohort discovery platform integrated with major EHRs (e.g., Epic, Cerner); directly comparable to Deep Lens in serving community oncology and health system research sites.
- Massive Bio: AI-powered clinical trial matching focused on oncology, connecting patients and providers to trials through a virtual research site model; overlaps directly with Deep Lens on oncology patient recruitment use cases.
Broad incumbents
- IQVIA (Orchestrated Patient Engagement / E360): Largest CRO and clinical-tech incumbent offering EDC, feasibility, site selection, and patient recruitment within its broader services portfolio; sets the competitive reference for sponsors evaluating point solutions like Deep Lens.
- Medidata (Dassault Systèmes): Leading clinical trial data capture and analytics platform with patient-centric trial modules; competes for sponsor budgets on EDC, eCOA, and trial data collection where Deep Lens also plays.
- Veeva Systems: Enterprise cloud platform for life sciences with Vault CTMS, EDC, and trial operations; comparable incumbent vendor competing for sponsor clinical technology wallet share relevant to Deep Lens.
- TriNetX: Global health research network providing real-world data and protocol feasibility for clinical trials; overlaps with Deep Lens on the sponsor-side feasibility and cohort query use cases.
Emerging players
- Trial Library: Technology-enabled network of community oncology sites for trial recruitment and real-world research; overlaps with Deep Lens on community-site oncology trial enablement.
- Antidote (Trial Library acquisition lineage): Patient-facing clinical trial matching platform historically focused on consumer-driven recruitment; relevant adjacent peer in the patient-trial matching category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Deep Lens social profiles
Digital presenceDeep Lens financial estimates
Financial estimateRevenue estimate
Valuation estimate
Deep Lens leadership team
Management profileNumber of profiles
Profiles2 records
Deep Lens funding detail
Funding detailFunding overview
Funding rounds2 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Deep Lens M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Deep Lens
What does Deep Lens do?
Deep Lens (now operating as Paradigm Health) provides an AI-powered clinical trial recruitment and patient identification platform. The company matches patients to oncology and other clinical trials by integrating with electronic health record (EHR) data at research sites, enabling sponsors and sites to accelerate enrollment, optimize protocol design, and improve feasibility assessment.
When was Deep Lens founded?
Deep Lens was founded in 2017. It employs 11 to 50 people.
Where is Deep Lens based?
Deep Lens is headquartered in Columbus, United States, in the North America region.
How does Deep Lens make money?
Two revenue lines are on record. Platform Services for Sponsors are the primary driver. The others are provider Integration Services.
Who are Deep Lens's main competitors?
Direct peers on record are Deep 6 AI, Mendel, BEKhealth and Massive Bio. Broad incumbents are IQVIA (Orchestrated Patient Engagement / E360), Medidata (Dassault Systèmes), Veeva Systems and TriNetX. Emerging players are Trial Library and Antidote (Trial Library acquisition lineage).
Does Deep Lens have an API?
No public API is recorded for Deep Lens.
What industry is Deep Lens in?
Deep Lens's product category is Clinical Trial Technology. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials), with a secondary code of HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems). Its NAICS code is 54151 and its SIC code is 8000.